Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma

Pathology Research and Practice

Volumn 207, Issue 8, 2011, Pages 479-486

  Barresi, Valeria ^a   Reggiani Bonetti, Luca ^b   Di Gregorio, Carmela ^b   Vitarelli, Enrica ^a   Ponz De Leon, Maurizio ^b   Barresi, Gaetano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Angiogenesis; Colorectal carcinoma; MMP 9; NGAL; Prognosis; Stage I; TNM

Indexed keywords

GELATINASE B; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE STUDY;

ACUTE-PHASE PROTEINS; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIPOCALINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 80051791317     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.05.012     Document Type: Article

References (63)

1. Barresi V., Cerasoli S., Vitarelli E., Tuccari G. Density of microvessel positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol. 2007, 114:147-156.
2. Barresi V., Cerasoli S., Tuccari G. Correlative evidence that tumour cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 2008, 28:472-478.
3. Barresi V., Vitarelli, Tuccari G., Barresi G. Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch. Pathol. Lab. Med. 2008, 132:1807-1812.
4. Barresi V., Vitarelli E., Cerasoli S. Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch. 2009, 454:563-571.
5. Barresi V., Di Gregorio C., Regiani-Bonetti L., Ponz de Leon M., Barresi G. Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. Virchows Arch. 2010, 457:11-19.
6. Barresi V., Ieni A., Bolignano D., Magno C., Buemi M., Barresi G. Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. Oncol. Rep. 2010, 24:305-310.
7. Barresi V., Lucianò R., Vitarelli E., Labate A., Tuccari G., Barresi G. Neutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: a stage-specific prognostic factor?. Oncol. Lett. 2010, 1:1089-1096.
8. Barresi V., Tuccari G. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Neuropathology 2010, 30:537-546.
9. Barresi V., Tuccari G., Barresi G. NGAL immunohistochemical expression in brain primary and metastatic tumors. Clin. Neuropathol. 2010, 29:317-322.
10. Barresi V., Vitarelli E., Tuccari G., Barresi G. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?. J. Neurooncol. 2011, 102:189-196.
11. Barresi V., Di Gregorio C., Reggiani-Bonetti L., Ieni A., Ponz-De Leon M., Barresi G. Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?. Hum. Pathol. 2011, (Epub ahead of print).
12. Bauer M., Eickhoff J.C., Gould M.N., Mundhenke C., Maas N., Friedl A A. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res. Treat. 2008, 108:389-397.
13. Bousserouel S., Kauntz H., Gossé F., Bouhadjar M., Soler L., Marescaux J., Raul F. Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis. Int. J. Oncol. 2010, 36:1485-1490.
14. Bratt T. Lipocalins and cancer. Biochim. Biophys. Acta 2000, 1482:318-326.
15. Burrows F.J., Derbyshire E.J., Tazzari P.L., Amlot P., Gazdar A.F., King S.W., Letarte M., Vitetta E.S., Thorpe P.E. Up-regulation of endoglin on vascular endothelial cells in human solid tumours: implications for diagnosis and therapy. Clin. Cancer Res. 1995, 1:1623-1634.
16. Buss J.L., Greene B.T., Turner J., Torti F.M., Torti S.V. Iron chelators in cancer chemotherapy. Curr. Top. Med. Chem. 2004, 4:1623-1635.
17. Cheifetz S., Bellón T., Calés C., Vera S., Bernabeu C., Massagué J., Letarte M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 1992, 267:19027-19030.
18. Compton C.C., Greene F.L. The staging of colorectal cancer: 2004 and beyond. CA Cancer J. Clin. 2004, 54:295-308.
19. Cowland J.B., Borregaard N N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45:17-23.
20. Curran S., Dundas S.R., Buxton J., Leeman M.F., Ramsay R., Murray G.I. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin. Cancer Res. 2004, 10:8229-8234.
21. Devireddy L.R., Gazin C., Zhu X., Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005, 23:1293-1305.
22. Di Gregorio C., Fante R., Roncucci L., Tamassia M.G., Losi L L., Benatti P., Pedroni M., Percesepe A., De Pietri S., Ponz de Leon M. Clinical features, frequency and prognosis of Dukes' A colorectal carcinoma: a population-based investigation. Eur. J. Cancer 1996, 32A:1957-1962.
23. Fernandez C.A., Yan L., Louis G., Yang J., Kutok J.L., Moses M.A. The matrix metallo-proteinase-9/neutrophil gelatinase associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin. Cancer Res. 2005, 11:5390-5395.
24. Fonsatti E., Del Vecchio L., Altomonte M. Endoglin: an accessory component of the TGF-β-binding receptor complex with diagnostic, prognostic, and bio-immunotherapeutic potential in human malignancies. J. Cell. Physiol. 2001, 188:1-7.
25. Friedl A A., Stoesz S.P., Buckley P., Gould M.N. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem. J. 1999, 31:433-441.
26. Goetz D.H., Willie S.T., Arme R.S., Bratt T., Borregaard N., Strong R.K. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 2000, 39:1935-1941.
27. Guzińska-Ustymowicz K. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC). Anticancer Res. 2006, 26:1589-1594.
28. Gwira J.A., Wei F., Ishibe S. Expression of neutrophil associated-gelatinase lipocalin regulates epithelial morphogenesis in vitro. J. Biol. Chem. 2005, 280:7875-7882.
29. Herszényi L., Sipos F., Galamb O., Solymosi N., Hritz I., Miheller P., Berczi L., Molnár B., Tulassay Z. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia adenocarcinoma sequence of the colon. Pathol. Oncol. Res. 2008, 14:31-37.
30. Hu L., Hittelman W., Lu T., Ji P., Arlinghaus R., Shmulevich I., Hamilton S.R., Zhang W. NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab. Invest. 2009, 89:531-548.
31. Iannetti A., Pacifico F., Acquaviva R., Lavorgna A., Crescenzi E., Vascotto C., Tell G., Salzano A.M., Scaloni A., Vuttariello E., Chiappetta G., Formisano S., Leonardi A. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14058-14063.
32. Jensen S.A., Vainer B., Bartels A., et al. Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - associations with histopathology and patients outcome. Eur. J. Cancer 2010, 46:3233-3242.
33. Jones D.T., Trowbridge I.S., Harris A.L. Effects of transferring receptor blockade on cancer cell proliferation and hypoxia inducible factor function and their differential regulation by ascorbate. Cancer Res. 2006, 66:2749-2756.
34. Kang J.C., Chen J.S., Lee C.H., Chang J.J., Shieh Y.S. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J. Surg. Oncol. 2010, 102:242-248.
35. Kubben F.J., Sier C.F., Hawinkels L.J., Witte A.M., Veenendaal R.A., van Duijn W., Verheijen J.H., Hanemaaijer R., Lamers C.B., Verspaget H.W. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur. J. Cancer 2007, 43:1869-1876.
36. Landis S.H., Murray T., Bolden S. Cancer statistics. Cancer J. Clin. 1999, 49:8-31.
37. Langers A.M., Sier C.F., Hawinkels L.J., Kubben F.J., van Duijn W., van der Reijden J.J., Lamers C.B., Hommes D.W., Verspaget H.W. MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. Br. J. Cancer 2008, 98:1820-1823.
38. Le N.T.V., Richardson D.R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 2002, 1603:3146.
39. Lee S., Jilani S.M., Nikolova G.V., Carpizo D., Iruela-Arispe M.L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 2005, 169:681-691.
40. Lubbe W.J., Zhou Z.Y., Fu W., Zuzga D., Schulz S., Fridman R R., Muschel R.J., Waldman S.A., Pitari G.M. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin. Cancer Res. 2006, 12:1876-1882.
41. Lubbe W.J., Zuzga D.S., Zhou Z., Fu W., Pelta-Heller J., Muschel R.J., Waldman S.A., Pitari G.M. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res. 2009, 69:3529-3536.
42. Miller D.W., Graulich W., Karges B. Elevated expression of endoglin, a component of the TGF-β receptor complex, correlates with proliferation of tumour endothelial cells. Int. J. Cancer 1999, 81:568-572.
43. Mori K., Yang J., Barasch Ureteric bud controls multiple steps in the conversion of mesenchyme to epithelia. Semin. Cell Dev. Biol. 2003, 14:209-216.
44. Morodomi T., Isomoto H., Shirouzu G., Shirouzu K., Kakegawa K., Irie K., Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancers. Cancer 1989, 63:539-543.
45. Nielsen B.S., Borregaard N., Bundgaard J.R., Timshel S., Sehested M., Kjeldsen L L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996, 38:414-420.
46. Niu J., Gu X., Turton J., Meldrum C., Howard E.W., Agrez M. Integrin-mediated signaling of gelatinase B secretion in colon cancer cells. Biochem. Biophys. Res. Commun. 1998, 249:287-291.
47. Noel A., Jost M., Maquoi E. Matrix metalloproteinases at cancer tumour-host interface. Semin. Cell Dev. Biol. 2008, 19:52-60.
48. Saad R.S., Liu Y.L., Nathan G., Celebrezze J., Medich D., Silverman J.F. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod. Pathol. 2004, 17:197-203.
49. Sobin L.H., Wittekind C. TNM classification of malignant tumors. International Union Against Cancer (UICC) 2002, Wiley-Liss, New York. 6th ed.
50. Stoesz S.P., Friedl A., Haag J.D., Lindstrom M.J., Clark G.M., Gould M.N. Heterogeneous expression of the lipocalin NGAL in primary breast cancer. Breast Cancer Res. Treat. 1998, 79:565-572.
51. Tong Z., Kunnumakkara A.B., Wang H. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008, 68:6100-6108.
52. Torsney E., Charlton R., Parums D., Collis M., Arthur H.M. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm. Res. 2002, 51:464-470.
53. Toyokuni S S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009, 100:9-16.
54. Tanaka M., Hashiguchi Y., Ueno H., Hase K., Mochizuki H. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis. Colon Rectum 2003, 46:1054-1059.
55. Wichmann M.W., Muller C., Hornung H.M. Results of long-term follow-up after curative resection of Dukes' A colorectal cancer. World J. Surg. 2002, 26:732-736. The Colorectal Cancer study Group.
56. Wiggers T., Arends J.W., Schutter B., Volovics L., Bosman F.T. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988, 61:386-389.
57. Wu X.C., Chen V.W., Steele B., Ruiz B., Fulton J., Liu L., Carozza S.E., Greenlee R. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group. Cancer 2001, 92:2547-2554.
58. Yan L., Borregaard N., Kjeldsen L., Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 2001, 276:37258-37265.
59. Yang J., Goetz D., Li J.Y., Wang W., Mori K., Setlik D. An iron delivery pathway mediated by a lipocalin. Mol. Cell 2002, 10:1045-1056.
60. Zeng Z.S., Cohen A.M., Guillem J.G. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 andMMP-9) during human colorectal tumorigenesis. Carcinogenesis 1999, 20:749-755.
61. Zhang H., Xu L., Xiao D., Xie J., Zeng H., Wang Z., Zhang X., Niu Y., Shen Z., Shen J., Wu X., Li E. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J. Clin. Pathol. 2007, 60:555-561.
62. Zhang X.F., Zhang Y., Zhang X.H., Zhou S.M., Yang G.G., Wang O.C., Guo G.L., Yang G.Y., Hu X.Q. Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) expression in primary rectal cancer. BMC Cancer 2009, 9:134.
63. Zuzga D., Gibbons A.V., Li P., et al. Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis. Clin. Transl. Sci. 2008, 1:136-141.